O6-Methylguanine-DNA-Methyltransferase (MGMT) Antikörper

Antigen: O6-Methylguanine-DNA-Methyltransferase (MGMT)

Synonyme: MGMT

Klonalität: Monoklonal (MT3-1)

Wirt: Maus

Reaktivität: Human

Applikation: Immunhistochemie (IHC)

Produktnummer: ABIN125221

Produktbeschreibung

Immunogen: Recombinant human MGMT protein.

Format: Supernatant

Isotyp: IgG1  (Passende Sekundärantikörper)

Klon: MT3-1

Spezifität: O6-Methylguanine-DNA-Methyltransferase (MGMT) is a 22 kD human DNA repair protein that removes O6-alkylguanine DNA adducts. MGMT acts as a suicide acceptor protein repairing the DNA by accepting alkyl groups and consequently inactivating itself. This antibody stains all mantle zone lymphocytes and 50%of germinal center lymphocytes. Basaloid epithelial cells of tonsil squamous mucosa were also stained positive with this antibody.

Anwendungen

Applikationshinweise: Titer/Working Dilution: This antibody may be diluted to a titer of 1:25-1:50 in an ABC method. However, depending on the staining conditions employed, we suggest that final dilution should be determined by the user. Staining Protocol: We suggest an incubation period of 30-60 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation should be determined by the user. High temperature treatment of formalin-fixed tissue sections with 10 mM citrate buffer, pH 6.0 must be performed prior to the immunostaining. Positive Control: Tonsil. Cellular localization: Nuclear and cytoplasmic

Konzentration: 100ug/ml approximately

Buffer: This antibody is supplied as tissue culture supernatant containing sodium azide as preservative.

Lagerung: Store the antibody at 2-8o c. Do not use it beyond the expiration date stated on the label.

Beschränkungen: Für Forschungszwecke. Als CE-zertifizierter Antikörper in der Europäischen Union für In Vitro Diagnostik (IVD) zugelassen.

Publikationen

Publikationen: Egyhuazi, Hansson, Ringborg: "O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours." in: British journal of cancer, Vol. 71, Issue 1, pp. 37-9, 1995 (PubMed).

Matsukura, Miyazaki, Yakushiji et al.: "Expression and prognostic significance of O6-methylguanine-DNA methyltransferase in hepatocellular, gastric, and breast cancers." in: Annals of surgical oncology, Vol. 8, Issue 10, pp. 807-16, 2002 (PubMed).

Gerson: "Clinical relevance of MGMT in the treatment of cancer." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 20, Issue 9, pp. 2388-99, 2002 (PubMed).